Sorrento Therapeutics Inc
* ABG Management's Yu Fan reports 12.2 percent stake in Sorrento Therapeutics as of July 10 - SEC filing
* ABG Management 's Yu Fan says intends to engage in discussions with Sorrento Therapeutics that may relate to governance and board composition Source text for Eikon: Further company coverage:
